| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Eliem Therapeutics Inc Common Stock (NASDAQ: ELYM)
ELYM Technical Analysis
5
| As on 9th Jun 2023 ELYM STOCK Price closed @ 2.92 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.64 & Strong Sell for SHORT-TERM with Stoploss of 9.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ELYMSTOCK Price
| Open | 3.07 | Change | Price | % |
| High | 3.08 | 1 Day | -0.06 | -2.01 |
| Low | 2.92 | 1 Week | -0.08 | -2.67 |
| Close | 2.92 | 1 Month | -0.28 | -8.75 |
| Volume | 2000 | 1 Year | -6.97 | -70.48 |
| 52 Week High 14.19 | 52 Week Low 2.30 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ELYM Daily Charts |
ELYM Intraday Charts |
Whats New @ Bazaartrend |
ELYM Free Analysis |
|
|
ELYM Important Levels Intraday
| RESISTANCE | 3.23 |
| RESISTANCE | 3.13 |
| RESISTANCE | 3.07 |
| RESISTANCE | 3.01 |
| SUPPORT | 2.83 |
| SUPPORT | 2.77 |
| SUPPORT | 2.71 |
| SUPPORT | 2.61 |
ELYM Forecast May 2024
| 4th UP Forecast | 14.04 |
| 3rd UP Forecast | 10.47 |
| 2nd UP Forecast | 8.27 |
| 1st UP Forecast | 6.06 |
| 1st DOWN Forecast | -0.22 |
| 2nd DOWN Forecast | -2.43 |
| 3rd DOWN Forecast | -4.63 |
| 4th DOWN Forecast | -8.2 |
ELYM Weekly Forecast
| 4th UP Forecast | 14.02 |
| 3rd UP Forecast | 10.46 |
| 2nd UP Forecast | 8.26 |
| 1st UP Forecast | 6.06 |
| 1st DOWN Forecast | -0.22 |
| 2nd DOWN Forecast | -2.42 |
| 3rd DOWN Forecast | -4.62 |
| 4th DOWN Forecast | -8.18 |
ELYM Forecast2024
| 4th UP Forecast | 27.53 |
| 3rd UP Forecast | 19.64 |
| 2nd UP Forecast | 14.76 |
| 1st UP Forecast | 9.88 |
| 1st DOWN Forecast | -4.04 |
| 2nd DOWN Forecast | -8.92 |
| 3rd DOWN Forecast | -13.8 |
| 4th DOWN Forecast | -21.69 |
Eliem Therapeutics Inc Common Stock ( NASDAQ USA Symbol : ELYM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ELYM Business Profile
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain and ETX-155 for major depressive disorder, perimenopausal depression, and focal onset seizures. The company also develops preclinical pipeline programs, such as Kv7 Program for pain epilepsy; and Anxiolytic for the treatment of generalized anxiety. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Address: 23515 NE Novelty Hill Road, Redmond, WA, United States, 98053
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service